?Cerebral Vascular Disease.
?Intracranial Tumor Surgery.
?Traumatic Brain Injury (TBI).
?Spinal Cord Injury.
--- Content provided by FirstRanker.com ---
?Intraoperative Neurophysiology Monitoring.?Sedation in Paediatric Patients With Neurosurgical Diseases.
?Benefits of Analgesia in Neurosurgery.
?The Neurocritical Care Unit.
?Awake Craniotomy.
--- Content provided by FirstRanker.com ---
?Epilepsy Surgeries Requiring Intraoperative Mapping.?Stereotactic Neurosurgery/Deep Brain Stimulation.
? Summary
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)1
INTRODUCTION
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)
2
--- Content provided by FirstRanker.com ---
? Dexmedetomidine is a highly selective 2-adrenergic receptor agonist acting on central
presynaptic 2-receptors primarily in the pontine locus ceruleus and peripheral postsynaptic 2-
--- Content provided by FirstRanker.com ---
receptors on vascular smooth muscle.? The 2-adrenergic receptor agonist dexmedetomidine has sedative, anxiolytic, analgesic, and
sympatholytic effects.
--- Content provided by FirstRanker.com ---
? The potential advantages are:
?Neuroprotection
?Minimal impact on neuronal function including less interruption of neurophysiological
--- Content provided by FirstRanker.com ---
monitoring
?No increase in intracranial pressure (ICP).
?In healthy subjects receiving dexmedetomidine, cerebral metabolic rate of oxygen
--- Content provided by FirstRanker.com ---
consumption (CMRO2) is decreased with CMRO2-CBF coupling unchanged, indicating that
brain tissue oxygen delivery is little affected
--- Content provided by FirstRanker.com ---
?Stable hemodynamics?Opioid and anesthesia sparing effects
?Minimal respiratory depression and maintenance of airway reflexes and patency during
awake procedures.
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)
3
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)4
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
5(PDCC Neuroanaesthesia)
6
--- Content provided by FirstRanker.com ---
ROLE OF DEXMEDETOMIDINE IN CLINICALNEUROSURGICAL ANAESTHESIA
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
7
CEREBRAL VASCULAR DISEASE
--- Content provided by FirstRanker.com ---
? Carotid endarterectomy (CEA):?Patients frequently have concomitant peripheral vascular disease and other related
comorbidities, and are prone to hemodynamic fluctuations caused by surgical stimulation or
--- Content provided by FirstRanker.com ---
perioperative medications.?Intraoperative hypotension and the reduction in CBF caused by dexmedetomidine can
potentially risk inadequate oxygen delivery that may necessitate the use of intracarotid shunts
--- Content provided by FirstRanker.com ---
during awake CEA (although a prospective case series showed that dexmedetomidine as the
primary sedative did not increase the incidence of shunts as compared with historical controls.
--- Content provided by FirstRanker.com ---
?Hypotensive episodes in the post anesthesia care unit after CEA, however, are more frequentwith dexmedetomidine, and patients may require more hemodynamic interventions.
?There is no direct clinical evidence that dexmedetomidine exacerbates impaired dynamic
--- Content provided by FirstRanker.com ---
cerebral vascular autoregulation in carotid artery stenosis.
?Similarly, there is no human evidence that dexmedetomidine worsens or causes cerebral
--- Content provided by FirstRanker.com ---
ischemia, although high-dose dexmedetomidine was found to be associated with ischemic braininjury exacerbation in animals.
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
8
? Intracranial aneurysm/ SAH/ AVM/ ICH:
?The relationship between CBF and CMRO2 is preserved when using dexmedetomidine in patients
--- Content provided by FirstRanker.com ---
with unruptured intracranial aneurysms or arterial venous malformation.?In a small retrospective study, sedation after unruptured cerebral aneurysm clipping with
dexmedetomidine infusion (0.4 to 0.9 g/kg/h) showed comparable blood pressure to propofol
--- Content provided by FirstRanker.com ---
(0.5 to 5.0mg/kg/h), but with a lower heart rate.
?Sixty-six percent of dexmedetomidine sedated patients, however, required additional propofol
--- Content provided by FirstRanker.com ---
boluses to prevent agitation while intubated.?In a recent case series of 12 patients, coil embolization of intracranial aneurysms was performed
successfully under monitored anesthesia care (MAC) with dexmedetomidine without adverse
--- Content provided by FirstRanker.com ---
hemodynamic or respiratory events.
?Nevertheless, these case series are retrospective and underpowered, and prospective
--- Content provided by FirstRanker.com ---
randomized trials are needed to elucidate the effectiveness and safety of addingdexmedetomidine during intracranial aneurysm surgery, which requires systemic and cerebral
hemodynamic stability.
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)
9
--- Content provided by FirstRanker.com ---
?Animal studies of SAH with cerebral vasospasm have found that dexmedetomidine attenuatedbrain edema, reduced vasospasm, and ameliorated neurological deficits.
?However, clinical neuronal protection related to dexmedetomidine use in patients with SAH has
--- Content provided by FirstRanker.com ---
not been confirmed.
?Animal studies have implied that after focal cerebral infarction, dexmedetomidine infusion
--- Content provided by FirstRanker.com ---
improved microregional oxygen supply/consumption balance, thereby decreasing corticalinfarction size with more cell survival compared with saline. This neuronal protective effect of
dexmedetomidine was stronger when combined with propofol or lidocaine.
--- Content provided by FirstRanker.com ---
?However, this neuroprotective effect in cerebral ischemia was not mediated by central -
adrenoceptors and not related to the inhibition of presynaptic norepinephrine or glutamate
--- Content provided by FirstRanker.com ---
release, but rather by inhibiting the stress hormone and inflammatory response, as well asthrough activation of a signaling pathway of cell growth, proliferation, and survival.
?In response to stroke, certain inflammatory mediators and stress hormones are activated, which
--- Content provided by FirstRanker.com ---
can be inhibited by dexmedetomidine based on preclinical studies.
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
10INTRACRANIAL TUMOR SURGERY
? Dexmedetomidine prevents sudden increases in ICP and brain swelling.
? As an anesthetic adjuvant results in less cardiovascular variability during operations and an early
--- Content provided by FirstRanker.com ---
emergence.
? In a prospective randomized controlled trial, infusing dexmedetomidine at 0.7 g/kg/h as an
--- Content provided by FirstRanker.com ---
adjunct to propofol-fentanyl anesthesia in this setting improved hemodynamic stability andreduced fentanyl and antihypertensive agent consumption.
? A systematic review of 254 patients from 5 randomized controlled trials involving functional
--- Content provided by FirstRanker.com ---
endoscopic sinus surgery found that dexmedetomidine provided better surgical visibility than
saline control or sevoflurane alone as its hypotensive action and hemodynamic stability reduced
--- Content provided by FirstRanker.com ---
intraoperative bleeding, although the quality of the operative field was similar amongdexmedetomidine, esmolol, and remifentanil groups.
? In a recent randomized controlled trial, 4 commonly used anesthetic agents for neurosurgery with
--- Content provided by FirstRanker.com ---
different mechanisms of action (midazolam, propofol, fentanyl, and dexmedetomidine) were
titrated to an equivalent mild sedation in patients with supratentorial mass lesions before any
--- Content provided by FirstRanker.com ---
surgical intervention. Dexmedetomidine compared with the other agents resulted in a muchlower incidence of unmasked or exacerbated neurological deficits.
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
11
? A recent animal study found 2-adrenoceptor expression in C6 glioma cells (a malignant glioma
--- Content provided by FirstRanker.com ---
cell line), so that dexmedetomidine may have an interaction with the tumor through regulatingmultiple molecular signal pathways and directly activating 2-adrenoceptors in gliomas.
? This seems to indicate that the "response" of tumors to anesthetics is strongly associated with the
--- Content provided by FirstRanker.com ---
tumors' histologic properties.
? Therefore, to evaluate dexemedetomidine's effects on neurological outcome in brain tumor
--- Content provided by FirstRanker.com ---
patients, extensive disease-centered studies with carefully defined clinical phenotypes areneeded.
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
12
TRAUMATIC BRAIN INJURY (TBI)
? Sedation in TBI may have therapeutic significance besides facilitating airway control.
--- Content provided by FirstRanker.com ---
? The purpose of sedation in TBI includes optimizing CMRO2 and CBF, reducing elevated ICP, andpreventing secondary brain injury.
? In a retrospective case series, in which 85 severe TBI patients in the intensive care unit (ICU)
--- Content provided by FirstRanker.com ---
received a median dose of dexmedetomidine of 0.49 g/kg/h for 32 hours (median infusion
period) to maintain "cooperative sedation," midazolam and propofol requirements nearly
--- Content provided by FirstRanker.com ---
disappeared indicating the effectiveness of dexmedetomidine as the sole agent for mild sedationfor TBI patients.
? Another prospective study observed 198 severe TBI patients who received dexmedetomidine
--- Content provided by FirstRanker.com ---
and/or propofol sedation. Dexmedetomidine was associated with longer "calm to light
sedation" targets compared with propofol alone in the first 7 days after infusion.
--- Content provided by FirstRanker.com ---
? Although dexmedetomidine was associated with a higher degree of hypotension compared withpropofol, there were no differences in adverse events between the groups.
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
13
? A case report of an alcohol-dependent TBI patient showed that dexmedetomidine as a
--- Content provided by FirstRanker.com ---
continuous infusion (0.5 to 1.5 g/kg/h for 8 d) facilitated sedation and controlled agitationwhen benzodiazepine treatment failed, without neurological or respiratory depression.
? Systemic hypotension or hypertension can be disastrous for TBI patients with impaired cerebral
--- Content provided by FirstRanker.com ---
autoregulation because it can decrease cerebral perfusion pressure, increase ICP, and lead to
poor clinical outcomes.
--- Content provided by FirstRanker.com ---
? Moderate to severe TBI patients may also suffer paroxysmal sympathetic hyperactivity (PSH) dueto elevated ICP, which presents with elevated heart rate, blood pressure, respiratory rate,
temperature, sweating, and posturing.
--- Content provided by FirstRanker.com ---
? A case report showed that 0.2 to 0.7 g/kg/h dexmedetomidine continuous infusion effectively
controlled this syndrome when routine medication therapy failed.
--- Content provided by FirstRanker.com ---
? Another retrospective study included 90 severe TBI patients who received dexmedetomidine orpropofol/midazolam sedation in the neuro ICU for consecutive days, and found that the
dexmedetomidine regimen group had a lower probability to be diagnosed with PSH.
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)
14
SPINAL CORD INJURY
--- Content provided by FirstRanker.com ---
? Recent animal studies have found that intravenous dexmedetomidine attenuated spinal ventral
neuronal degeneration and preserved neurological function and neuronal viability after
--- Content provided by FirstRanker.com ---
transient spinal cord ischemia or ischemia-reperfusion.? These beneficial effects were associated with improved cell survival and antiapoptotic factors, as
well as with the attenuation of microglial activation, proinflammatory cytokine production,
--- Content provided by FirstRanker.com ---
decreased interleukin-6, tumor necrosis factor-alpha, and reduced neutrophil infiltration, all of
which indicate an anti-inflammatory effect.
--- Content provided by FirstRanker.com ---
? Clinically, there is no direct evidence of improved functional outcome by virtue ofdexmedetomidine's theoretical spinal cord protective or anti-inflammatory effects.
? In a single case of a focal inflammatory spinal cord disorder, namely transverse myelitis,
--- Content provided by FirstRanker.com ---
hemodynamic instability was reported as the major concern response. In that case,
dexmedetomidine sedation resulted in severe hypertension and bradycardia, which may have
--- Content provided by FirstRanker.com ---
been due to an exaggerated peripheral vasoconstrictor response due to the lack of spinal reflexes.(PDCC Neuroanaesthesia)
15
--- Content provided by FirstRanker.com ---
? In terms of injury biomarkers, a prospective study found reduced levels of the stress hormone
cortisol and the inflammatory response marker interleukin-10 after intraoperative
--- Content provided by FirstRanker.com ---
dexmedetomidine infusion in cervical spine surgery.? However, those stress response biomarkers and cytokine concentrations could not be correlated
with any postoperative functional recovery parameter.
--- Content provided by FirstRanker.com ---
? Although dexmedetomidine does not attenuate the injury in patients with cervical cord lesions,
its practical use lies perhaps in helping to prevent secondary injury by facilitating awake
--- Content provided by FirstRanker.com ---
fiberoptic intubation.? A subsequent randomized controlled trial related to the performance of awake fiberoptic
intubation in simulated cervical injury patients found that adding dexmedetomidine sedation (1
--- Content provided by FirstRanker.com ---
g/kg bolus over 10min followed by 0.5 to 0.7 g/ kg/h) did not compromise hemodynamic
instability and resulted in better patient tolerance and satisfaction compared with the use of
--- Content provided by FirstRanker.com ---
midazolam alone.(PDCC Neuroanaesthesia)
16
--- Content provided by FirstRanker.com ---
INTRAOPERATIVE NEUROPHYSIOLOGY MONITORING? Intraoperative neurological injuries are usually detected as changes in the latencies or
amplitudes of evoked potentials (EPs).
--- Content provided by FirstRanker.com ---
? As such, intraoperative EP monitoring in spine surgeries should preferably be minimally affected
by the anesthetic regimen.
--- Content provided by FirstRanker.com ---
? Dexmedetomidine has been increasingly used to reduce the requirement of other anestheticsthat may impair EP signal acquisition, and its effects on EPs have been observed and investigated
thoroughly in spine surgery.
--- Content provided by FirstRanker.com ---
? SSEPs are generally well maintained under dexmedetomidine (0.2 to 0.7 g/kg/h) during spine
surgeries, with retention of the ability to monitor consistent and reproducible potentials.
--- Content provided by FirstRanker.com ---
? For motor evoked potentials (MEPs), most clinical studies found that clinically relevant doses ofdexmedetomidine also do not affect the signal, but patients receiving a higher loading dose (1
g/kg) or with a higher plasma concentration (0.8 ng/mL) do experience MEP amplitude
--- Content provided by FirstRanker.com ---
reduction or even signal loss.
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
17? Of note, all currently available evidence regarding the effects of dexmedetomidine on EPs stems
from spine surgeries.
--- Content provided by FirstRanker.com ---
? The impact of dexmedetomidine on EPs in the setting of different neuronal pathologic diseases
may vary, especially for those with impaired cerebrospinal tracts.
--- Content provided by FirstRanker.com ---
? As for intracranial surgeries, knowledge of how dexmedetomidine affects EP acquisition and thelatencies and amplitudes of MEPs and SSEPs for intracranial tumor or cerebrovascular pathologies
is lacking.
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)
18
SEDATION IN PEDIATRIC PATIENTS WITH NEUROSURGICAL DISEASES
--- Content provided by FirstRanker.com ---
? Sedation is usually required for imaging studies (eg,magnetic resonance imaging [MRI], computed
tomography [CT]) in pediatric patients.
--- Content provided by FirstRanker.com ---
? Separation, confinement, and an unfamiliar environment create agitation and anxiety forchildren, and in situations in which general anesthesia may not be preferred, effective sedation
with minimal respiratory depression is highly beneficial.
--- Content provided by FirstRanker.com ---
? A previous review extensively summarized early clinical studies of using dexmedetomidine as the
primary or rescue sedative during MRI or CT examination in pediatric populations.
--- Content provided by FirstRanker.com ---
? In this review, dexmedetomidine was superior to midazolam but inferior to propofol inproviding effective sedation, and this may be because propofol led to fewer procedure
interruptions and better parental satisfaction according to a comparison study of 1- to 7-year old
--- Content provided by FirstRanker.com ---
children undergoing MRI with propofol or dexmedetomidine sedation.
? Furthermore, the recovery time was slower in the dexmedetomidine cohort compared with
--- Content provided by FirstRanker.com ---
those who received propofol.? However, the dosage of dexmedetomidine ranged widely, from 0.3 to 2 g/kg bolus over 10 to
15 minutes followed by 0.5 to 1.5 g/kg/h infusion rate, and there was no optimal dosage
--- Content provided by FirstRanker.com ---
identified.
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
19? For outpatient EEG monitoring in children, intravenously administered dexmedetomidine
provides effective sedation without agitation, hemodynamic fluctuation, or respiratory
--- Content provided by FirstRanker.com ---
depression, and was superior to midazolam in terms of minimum "drug effect" on the quality of
acquired EEG.
--- Content provided by FirstRanker.com ---
? Sedation for intracranial radiotherapy for a 21-month old child was reported to be safelyachieved with dexmedetomidine sedation, providing a smooth sedation "induction" and fairly
rapid recovery with airway protection.
--- Content provided by FirstRanker.com ---
? Perioperative infusion of dexmedetomidine at 0.2 g/kg/h as an adjunct sedative reduced
sevoflurane-related emergence delirium in children aged 1 to 10 years.
--- Content provided by FirstRanker.com ---
? Clinical research defining the optimal dosing strategy and duration of dexmedetomidine infusionfor sedation in pediatric TBI is lacking.
? Notably, dexmedetomidine was reported to be associated with significant bradycardia during
--- Content provided by FirstRanker.com ---
therapeutic hypothermia when combined with remifentanil for sedation in children with TBI.
? Despite the few animal studies there is a lack of clinical evidence regarding the potential
--- Content provided by FirstRanker.com ---
neuronal protective or toxic effects of dexmedetomidine in developing human brains followingneurological injury, or how dexmedetomidine affects CBF, CMRO2, and ICP in children.
? Further translational studies and clinical evidence are needed.
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)
20
BENEFITS OF ANALGESIA IN NEUROSURGERY
--- Content provided by FirstRanker.com ---
? Postoperative pain following craniotomy or spinal surgery may be significant and can lead to
postoperative agitation and hypertension, which should be properly managed to minimize
--- Content provided by FirstRanker.com ---
potential intracerebral haemorrhage and/or vasogenic edema.? Opioids are effective in controlling pain but may cause respiratory depression.
? Dexmedetomidine can maintain airway reflexes and patency in spontaneously breathing
--- Content provided by FirstRanker.com ---
patients while providing analgesic effects.? A previous meta-analysis included eight small sample size randomized controlled trials and found
that dexmedetomidine reduced intraoperative opioid consumption during intracranial
--- Content provided by FirstRanker.com ---
procedures, although the administration time and dose were variable among the included studies.
? Subsequent randomized controlled trials demonstrated that infusion of dexmedetomidine
--- Content provided by FirstRanker.com ---
between 0.2 and 0.7 g/kg/h during and after the operation reduced postoperative pain aftercraniotomy and spine surgeries.
? It should be noted that Dexmedetomidine analgesic effect was not as potent as that of
--- Content provided by FirstRanker.com ---
remifentanil, and those receiving dexmedetomidine had longer emergence times.
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
21? To avoid such delayed emergence, a particular study made use of a 0.4 or 0.8 g/kg bolus of
dexmedetomidine for 10 minutes 1 h before the end of supratentorial craniotomy, with its
--- Content provided by FirstRanker.com ---
secondary outcome showing less postsurgical pain compared with control during emergence and
after transport to the ICU.
--- Content provided by FirstRanker.com ---
? The analgesic efficacy of dexmedetomidine has also been shown in studies in spine surgery,mainly lumbar laminectomy, discectomy, or posterior lumbar interbody fusion. For spinal
tumor surgery, no retrospective or prospective study of dexmedetomidine's analgesic efficacy
--- Content provided by FirstRanker.com ---
was identified.
? Compared with oral clonidine premedication, dexmedetomidine possesses a noninferior opioid
--- Content provided by FirstRanker.com ---
and anesthetic-sparing effect, and equal postoperative recovery time, hemodynamic stability, andblood loss during spine surgery.
? A randomized controlled trial study found that intraoperative dexmedetomidine infusion at 0.5
--- Content provided by FirstRanker.com ---
g/kg/h compared with saline improved the quality of recovery and reduced fatigue in the early
postoperative period after major spine surgery, when continuously infusing 0.2 g/kg/h for
--- Content provided by FirstRanker.com ---
another 24 hours postoperatively.? The effectiveness of dexmedetomidine as an analgesic was demonstrated both when given as an
intravenous infusion and as an epidural injection.
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)
22
? Neither for craniotomy nor for spinal surgery has a standard dexmedetomidine administration
--- Content provided by FirstRanker.com ---
strategy been established with regards to dose, time of initiation, duration, and combination with
other drugs.
--- Content provided by FirstRanker.com ---
? Moreover, the intensity of pain varies with different craniotomy approaches, for example,supratentorial craniotomies are associated with less pain than infratentorial procedures.
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
23
THE NEUROCRITICAL CARE UNIT
--- Content provided by FirstRanker.com ---
? It is exceptionally important in the neurosurgical population to control agitation and provideanalgesia, so as to improve tolerance to mechanical ventilation and accelerate time to extubation
in order to maintain intracranial homeostasis and enable early neurological assessment.
--- Content provided by FirstRanker.com ---
? A recent well-designed randomized controlled trial compared the infusion of dexmedetomidine
for <7 days with saline in a propofol-based sedation regimen in the general ICU (including only a
--- Content provided by FirstRanker.com ---
few neurosurgical patients) in patients with agitated delirium and requiring mechanicalventilation. This study found that dexmedetomidine facilitated early extubation and was
associated with more ventilator-free hours.
--- Content provided by FirstRanker.com ---
? Another randomized control trial enrolled 150 craniotomy patients who were not extubated
when admitted to the neuro ICU, where dexmedetomidine infusion at 0.6 g/kg/h was initiated 2
--- Content provided by FirstRanker.com ---
hours after craniotomy and up until 30 minutes after extubation, or for a maximum 24 hours.Patients who received dexmedetomidine demonstrated a decreased incidence of agitation
compared with the saline group.
--- Content provided by FirstRanker.com ---
? Most studies do demonstrate a significant reduction of opioid requirement when using
dexmedetomidine, and this analgesic effect may be an important reason for less agitation and
--- Content provided by FirstRanker.com ---
better ventilator tolerance neurocritical care patients receiving continuous sedation.(PDCC Neuroanaesthesia)
24
--- Content provided by FirstRanker.com ---
? A retrospective propensity-matched cohort data analysis of 342 patients from 2 medical centersshowed that dexmedetomidine and propofol were associated with an equal prevalence of
hypotension (defined as MAP <60 mmHg, 23% vs. 26%) and bradycardia (defined as heart rate
--- Content provided by FirstRanker.com ---
<50 beats/min, 8.6% vs. 5.5%).
? However, other studies frequently demonstrate that dexmedetomidine is more commonly
--- Content provided by FirstRanker.com ---
associated with bradycardia, which requires close attention, especially with higher doses andlonger durations of infusion, as are used when weaning off other sedatives in the neurocritical
care unit.
--- Content provided by FirstRanker.com ---
? A prospective study found that dexmedetomidine improved cognitive function in neuro ICU for
patients without forebrain injury compared with propofol, which reduced cognitive function. This
--- Content provided by FirstRanker.com ---
was attributed to the better antiagitation and analgesic effects of dexmedetomidine(PDCC Neuroanaesthesia)
25
--- Content provided by FirstRanker.com ---
AWAKE CRANIOTOMY
? Awake craniotomy is performed in patients with intracranial lesions in or near eloquent brain
--- Content provided by FirstRanker.com ---
areas requiring cortical mapping and intraoperative neurofunctional testing to maximizeresection while reducing risk of disability.
? Two different anesthesia management regimens are advocated:
--- Content provided by FirstRanker.com ---
?The "asleep-awake-asleep" technique in which endotracheal intubation or laryngeal mask airwayplacement is performed for the asleep portions of the procedure, and
?The "awake-awake-awake" technique in which mild sedation without invasive airway
--- Content provided by FirstRanker.com ---
manipulation is used during the pre-mapping and post-mapping phases.
? Local anesthetic infiltration to the incision site and/or a scalp block is generally used with both
--- Content provided by FirstRanker.com ---
approaches.? Special anesthesia considerations during the "awake" portion of any such procedure include the
need for cooperative sedation and sufficient analgesia without respiratory depression, as well
--- Content provided by FirstRanker.com ---
as the need for minimal interference with neurofunctional testing or cortical mapping.
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
26? Solely propofol-based sedation with an unprotected airway in "asleep-awake-asleep"
craniotomy, compared with general anesthesia, carries the concerns of a higher incidence of
--- Content provided by FirstRanker.com ---
respiratory depression in obese patients, arterial haemoglobin desaturation, a higher level ofPaCO2, hypertension, hypotension, and tachycardia.
? Dexmedetomidine reported as a useful adjuvant during "awake" state sedation, or even as an
--- Content provided by FirstRanker.com ---
effective rescue sedative when a propofol-remifentanil regimen results in oversedation,
respiratory depression, or discomfort.
--- Content provided by FirstRanker.com ---
? Other case reports have demonstrated that planned endotracheal intubation or laryngeal maskairway placement was able to be avoided outright with the use of dexmedetomidine.
? In high-risk patients with airway compromise and severe comorbidities, continuous infusion of
--- Content provided by FirstRanker.com ---
dexmedetomidine (0.5 to 1.0 g/kg loading dose followed by 0.2 to 0.7 g/kg/h infusion) as the
primary sedative combined with scalp nerve block and small doses of opioid was reported to
--- Content provided by FirstRanker.com ---
facilitate prolonged and complex "awake" procedures without any airway manipulation required.? Dexmedetomidine was well-tolerated in obstructive sleep apnea patients who needed
continuous positive airway pressure during awake craniotomy.
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)
27
--- Content provided by FirstRanker.com ---
? A recent prospective, randomized study compared dexmedetomidine to propofol-remifentanilbased conscious sedation in awake craniotomy for supratentorial tumor resection, in which the
incidence of respiratory depression or airway obstruction was 20% with propofol-remifentanil
--- Content provided by FirstRanker.com ---
sedation versus zero in the dexmedetomidine group.
? Nevertheless, both strategies achieved the same efficacy of sedation and ability to provide
--- Content provided by FirstRanker.com ---
adequate conditions for intraoperative mapping.? To avoid neurofunctional testing failure, dexmedetomidine is usually discontinued or reduced to
0.1 to 0.2 g/kg/h 10 to 20 minutes before mapping/testing and then resumed afterward.
--- Content provided by FirstRanker.com ---
? There is no evidence that the intraoperative conditions for testing provided by any sedative,
including dexmedetomidine or propofol, can be linked to better or worse postoperative
--- Content provided by FirstRanker.com ---
neurological outcomes.? In a particular case, dexmedetomidine was successfully used for awake craniotomy in a pregnant
patient with oligoastrocytoma without notable maternal or fetal adverse effects, its success being
--- Content provided by FirstRanker.com ---
attributed to its central sedative and analgesic effects.
? However, the safety of using dexmedetomidine in the obstetric population is still unclear.
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)28
EPILEPSY SURGERIES REQUIRING INTRAOPERATIVE MAPPING
--- Content provided by FirstRanker.com ---
? Localization of seizure foci and monitoring of brain function in epilepsy surgeries are crucial, andthese are usually achieved by use of the electroencephalogram (EEG) and/or
electrocorticography (ECoG).
--- Content provided by FirstRanker.com ---
? As these monitoring modalities are readily affected by most anesthetic agents, understanding the
benefits and drawbacks of dexmedetomidine and its interaction with EEG/ECoG monitoring in the
--- Content provided by FirstRanker.com ---
epilepsy population is important.? For example, a reduced seizure threshold caused by dexmedetomidine might result in a false-
positive leading to an "over-aggressive" resection, while abolished epileptiform discharges may
--- Content provided by FirstRanker.com ---
cause a false-negative and result in surgical resection being aborted.
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
29? As dexmedetomidine has the property of reducing central noradrenergic transmission, early
studies proposed proconvulsant effects of dexmedetomidine and seizure threshold reduction.
--- Content provided by FirstRanker.com ---
? Conversely, in other animal models, dexmedetomidine increased seizure threshold.
? This inconsistency may stem from seizure architectures involving different neurotransmitter
pathways that may be modulated by dexmedetomidine to generate proconvulsant or
--- Content provided by FirstRanker.com ---
anticonvulsant effects.
? The interaction between dexmedetomidine and different central nerve system excitatory agents
--- Content provided by FirstRanker.com ---
implies disparate impacts on EEG interpretation.? Although ECoG and EEG are well preserved as a whole and no major adverse clinical effects have
been described following dexmedetomidine, there have been cases exhibiting increased seizure
--- Content provided by FirstRanker.com ---
foci activity thereby challenging the suggestion that dexmedetomidine has anticonvulsant effects
in humans.
--- Content provided by FirstRanker.com ---
? While it remains unclear why the effects of dexmedetomidine on epileptiform activity arevariable, drug combinations, individual phenotypes, and preexisting neurological deficits may all
be contributing factors.
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)
30
? Small case series describe clinical experience with dexmedetomidine in adult patients undergoing
--- Content provided by FirstRanker.com ---
resection of epileptogenic foci, and report satisfactory operating conditions without a reduction
in epileptiform activity, the ability to obtain ECoG information, or the ability to perform cortical
--- Content provided by FirstRanker.com ---
mapping.? In general, a "low dose" is recommended, whereby administration can be started with a bolus
of 0.3 to 0.5 g/kg over 10 minutes followed by an infusion of 0.2 to 0.5 g/kg/h, remembering
--- Content provided by FirstRanker.com ---
that individual infusion rates vary.
? It is important to note, however, that patients with seizure disorders taking P450 enzyme?
--- Content provided by FirstRanker.com ---
inducing anticonvulsant medications (eg, phenytoin and carbamazepine) have an increasedplasma clearance of dexmedetomidine, indicating that higher doses might be necessary to
maintain the desired sedation level.
--- Content provided by FirstRanker.com ---
? While dexmedetomidine has been successfully used as an adjuvant during epilepsy surgeries,
future randomized controlled trials will be necessary to determine its proconvulsant or
--- Content provided by FirstRanker.com ---
anticonvulsant effects, especially in terms of dosing, drug combination, and interaction withspecific seizure characteristics in both the adult and pediatric populations.
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
31
STEREOTACTIC NEUROSURGERY/DEEP BRAIN STIMULATION
--- Content provided by FirstRanker.com ---
? Stereotactic neurosurgeries such as deep brain stimulator (DBS) placement are treatments forpatients with neurological movement disorders, for example, Parkinson disease (PD), Tourette
Syndrome, or Obsessive-Compulsive Disorder.
--- Content provided by FirstRanker.com ---
? The subthalamic nucleus, globus pallidus interna, and ventralis intermedius nucleus of the
thalamus are the 3 common target areas.
--- Content provided by FirstRanker.com ---
? The anesthetic considerations include an awake and cooperative patient, stable hemodynamics,maintenance of ventilation, airway reflexes and patency due to limited airway access because of
a head frame, as well as minimizing anesthetic interference with microelectrode recordings
--- Content provided by FirstRanker.com ---
(MER) and macrostimulation.
? Propofol is commonly used as the sole sedative during DBS placement under MAC, and these
--- Content provided by FirstRanker.com ---
cases may include scalp blocks and/or local anesthesia with a background infusion of short actingsedatives and narcotics (eg, remifentanil) during the procedure.
? Propofol can decrease subthalamic nucleus activity and interfere with MER, although this
--- Content provided by FirstRanker.com ---
interference can be terminated rapidly by stopping its administration.
? This suppression is mediated by GABA inhibitory pathways in the subthalamic nucleus and
--- Content provided by FirstRanker.com ---
globus pallidus that contain abundant GABAergic innervations.(PDCC Neuroanaesthesia)
32
--- Content provided by FirstRanker.com ---
? To avoid this, dexmedetomidine has been suggested as an alternative sedative agent.? It has been reported that dexmedetomidine (1.5 g/kg bolus over 20 min followed by 0.2 to 0.5
g/kg/h infusion) effectively controlled propofol-induced dyskinesia during bilateral subthalamic
--- Content provided by FirstRanker.com ---
nucleus DBS placement without adverse effect on MER.? Dexmedetomidine has been shown to possess other advantages in DBS surgeries ?
?Easily arousable sedation
--- Content provided by FirstRanker.com ---
?Good patient cooperation?No respiratory depression
?Anxiolytic
?Inhibit agitation and stress in prolonged surgery.
?Maintenance of hemodynamic stability.
--- Content provided by FirstRanker.com ---
? A 3-year retrospective study compared DBS surgeries performed with 0.3 to 0.8 g/kg/h
dexmedetomidine infusion titrating to Observer Assessment of Alertness and Sedation scale 4
--- Content provided by FirstRanker.com ---
versus patients without sedation, and found that dexmedetomidine not only protectedelectrophysiological mapping but also provided better hemodynamic stability.
(PDCC Neuroanaesthesia)
--- Content provided by FirstRanker.com ---
33
? Lower infusion rates of dexmedetomidine are recommended for DBS surgery.
? High-dose ( >0.8 g/kg/h) infusion should be avoided for several reasons ?
--- Content provided by FirstRanker.com ---
?Oversedation (bispectral index< 80) may abolish MER by suppressing neuronal firing,
decreasing background electrical activity and spike amplitudes, and thus delaying the
--- Content provided by FirstRanker.com ---
commencement of MER or causing failure to guide electrode placement.?Risk of respiratory suppression, especially in patients with obstructive sleep apnea.
?Clinically significant bradycardia.
--- Content provided by FirstRanker.com ---
? Anxiety and failure to cooperate are more frequent in pediatric awake stereotacticneurosurgeries, thus hampering the procedure and increasing the risk of intracerebral bleeding.
? A combination of dexmedetomidine and propofol infusion in pediatric DBS placement provided a
--- Content provided by FirstRanker.com ---
safe, efficacious, and well-tolerated sedation with minimal respiratory depression.
? The combination of three non-GABAergic agents (dexmedetomidine, ketamine, and opioids) in
--- Content provided by FirstRanker.com ---
pediatric DBS surgery might be an optional anesthesia strategy to preserve MERs(PDCC Neuroanaesthesia)
34
--- Content provided by FirstRanker.com ---
SUMMARY(PDCC Neuroanaesthesia)
35
--- Content provided by FirstRanker.com ---
? The prevailing thought is that dexmedetomidine may be associated with ?
?Less cerebral hemodynamic perturbation,
?Minimal neurophysiological monitoring interference,
--- Content provided by FirstRanker.com ---
?Greater ability to achieve cooperative sedation without respiratory compromise in awakeprocedures, and
?Acceptable pain control (alone or in combination with more potent analgesics).
--- Content provided by FirstRanker.com ---
? Low-range to mid-range infusion doses of dexmedetomidine seem to exert the above benefits in
perioperative neurosurgical care based on some current clinical evidence, although very notably
--- Content provided by FirstRanker.com ---
there is yet no standard dexmedetomidine administration strategy for these indications.? Dexmedetomidine may result in severe bradycardia and hypotension and hence, should be used
very cautiously in patients.
--- Content provided by FirstRanker.com ---
? It is not a potent analgesic in its own right, but rather should be considered as an adjunct to a
"true" analgesic, such as an opioid. remain.
--- Content provided by FirstRanker.com ---
? It is unclear whether it is proconvulsant or anticonvulsant, or how it affects EPs in differentcerebral pathologies, and there is a lack of clinical evidence regarding neuronal protection or
toxicity following neuronal injury in both children and adults.
--- Content provided by FirstRanker.com ---
? Further disease-based translational studies are required to understand both short-term and long-
term neurological and neurocognitive outcomes after dexmedetomidine administration.
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)36
THANK YOU
--- Content provided by FirstRanker.com ---
(PDCC Neuroanaesthesia)37